About Aberdare Ventures
Aberdare Ventures is a venture capital firm founded in 1999. It is primarily based out of San Francisco, United States. As of Sep 2018, Aberdare Ventures has invested in 42 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to HealthTech and Enterprise Applications. Most recently it participated in the $***** Series A round of Cricket Health Overall, Aberdare Ventures portfolio has seen 1 unicorn, 6 IPOs and 18 acquisitions including key companies like Omada, Indigo and Castlight. A lot of funds co-invest with Aberdare Ventures, with names like New Enterprise Associates sharing a substantial percentage of its portfolio. Aberdare Ventures has team of 4 people including 3 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A & 3 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Aberdare Ventures' List of Top Investments
Aberdare Ventures has a portfolio of 42 companies, one of which is a Unicorn. Their most notable investments are in Cervel and Aviir.Their portfolio spans across and United States. They have invested in Life Sciences, HealthTech, Enterprise Applications and 8 other sectors, across stages such as Series B, Series A and 3 more. Here is the list of top investments by Aberdare Ventures:
1. Omada
Provider of virtual care programs to manage chronic diseases. The company provides access to personal health coaches and specialists for virtual programs to deliver personalized interventions for prediabetes, diabetes, hypertension, and musculoskeletal issues.
Key facts about Omada
- Founded Year: 2011
- Location: San Francisco (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $450M
- Employee Count: 995 as on Aug 31, 2026
- Investors: Carriage House Rock, Perceptive Advisors and 45 Others
- Latest Funding Round: Series E, Feb 23, 2022, $*****
- Highlight: Public
2. Indigo
Provider of biological and sustainability solutions for the agriculture industry. The company offers biological products that harness the plant microbiome to protect crops. It also provides sustainability programs that help scale sustainable practices. These solutions aim to reduce emissions, conserve water, and improve farm profitability.
Key facts about Indigo
- Founded Year: 2013
- Location: Boston (United States)
- Valuation: $*****
- Stage: Series G
- Total Funding till date: $1.4B
- Employee Count: 1,322 as on Aug 31, 2026
- Investors: InvestX, Baillie Gifford and 26 Others
- Latest Funding Round: Series G, Sep 15, 2023, $*****
- Highlight: Editors' Pick
3. Castlight
Cloud-based healthcare information on providers and pricing for enterprises. It allows businesses to compare healthcare providers across a variety of metrics to optimize pricing and quality. Access to the data is through business to a business based subscription model. Only employees of companies who have enrolled are allowed access to the information on the platform The Company sets up consumer-oriented applications that enable employers to incorporate benefit programs into one platform.
Key facts about Castlight
- Founded Year: 2008
- Location: San Francisco (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2020
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $181M
- Employee Count: 360 as on Aug 31, 2026
- Investors: T. Rowe Price, Redmile Group and 10 Others
- Latest Funding Round: Series D, May 01, 2012, $*****
- Highlight: Acquired
Online EHR for private practice physicians to deliver patient-centered care. Its other solutions include charting, practice administration, and patient portals. The company claims to focus on user-experience research and design which allows a physician to see different pieces of information from their last visit and lab reports.
Key facts about Elation Health
- Founded Year: 2010
- Location: San Francisco (United States)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $108M
- Employee Count: 238 as on Aug 31, 2026
- Investors: Generation Investment Management, Threshold and 13 Others
- Latest Funding Round: Series D, Jul 26, 2022, $*****
- Highlight: Editors' Pick
Developer of therapeutics for gastrointestinal disorders. The company's lead product linaclotide is a guanylate cyclase-C (GC-C) agonist, which is indicated for irritable bowel syndrome with constipation and chronic idiopathic constipation. Also, it offers applications for pediatric GI diseases.
Key facts about Ironwood Pharma
- Founded Year: 1998
- Location: Cambridge (United States)
- Annual Revenue: $100M - $500M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $206M
- Employee Count: 262 as on Mar 31, 2026
- Investors: Athyrium Capital Management, Maverick Ventures and 15 Others
- Latest Funding Round: Post IPO, Aug 12, 2019, $*****
- Highlight: Public
Aberdare Ventures' Year-on-Year Investment Trends
Aberdare Ventures has invested in 42 companies over the last 24 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Cricket Health and most recent follow-on round was in Gravie.Aberdare Ventures' Investments by Stage
Aberdare Ventures has made 11 investments in Series B stage with an average round size of $24.9M, 8 investments in Series A stage with an average round size of $9.74M, 8 investments in Series C stage with an average round size of $41.8M, 4 investments in Seed stage with an average round size of $2.08M and 2 investments in Series D stage with an average round size of $44.4M.Stage of entry | No. of Investments |
|---|---|
Series B | 11 |
Series A | 8 |
Series C | 8 |
Seed | 4 |
Series D | 2 |
Note: We have considered here, only first round of investments
Aberdare Ventures' Investments by Sector
Aberdare Ventures has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, Enterprise Applications, Consumer and Sustainability Tech. Notably, it has invested in 37 Tech companies, 29 Enterprise (B2B) companies, 13 Software companies and at least 7 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 25 |
HealthTech | 11 |
Enterprise Applications | 8 |
Consumer | 6 |
Sustainability Tech | 3 |
Others | 11 |
Note: We have considered here, only first round of investments
Aberdare Ventures' Investments by Geography
Aberdare Ventures has made most investments in United States (33).Aberdare Ventures' recent investments
Aberdare Ventures has not made any investment in 2026 so far.Here are the most recent investments by Aberdare Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 05, 2018 | United States | Series A | 5159 | [+12] | |
May 18, 2018 | United States | Series C | 5887 | [+5] | |
Jul 18, 2017 | United States | Series C | 8137 | [+2] | |
Jun 07, 2016 | United States | Series C | 9641 | ||
Apr 06, 2016 | United States | Series C | 2950 | [+2] |
Unicorns in Aberdare Ventures' Portfolio
Aberdare Ventures has 1 unicorn in its portfolio - Indigo. The most recent unicorn in their portfolio is Indigo which became a unicorn in 2020, 6 years before Aberdare Ventures first invested in it.Here is a list of unicorns in Aberdare Ventures' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
78 | Provider of biological and sustainability solutions for the agriculture industry | 2013 | Boston | Series G | mp{bjcu |
IPOs and Publicly Listed companies in Aberdare Ventures' Portfolio
6 of Aberdare Ventures' portfolio companies have become public. Omada got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2025 at marketcap of $1.06B and Idun Pharmaceuticals got listed on the Stockholm Stock Exchange (STO).Here are Aberdare Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 06, 2025 | Dec 21, 2011 | Seed | 1349 | |
Mar 26, 2021 | Jun 14, 2004 | Series B | 4508 | |
Oct 11, 2019 | - | - | 4957 | |
Jul 25, 2013 | Feb 11, 2011 | Series B | 9310 | |
Feb 03, 2010 | Apr 03, 2002 | Series C | 8184 |
Acquired companies in Aberdare Ventures' Portfolio
18 companies from Aberdare Ventures' portfolio have been acquired. The most recent acquisition was Kezar Life Sciences in Mar 2026 by Aurinia Pharmaceuticals for $*****.Here are Aberdare Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 30, 2026 | - | - | 9479 | |
Feb 06, 2025 | Dec 04, 2006 | Seed | 8332 | |
Jan 05, 2022 | - | - | 6843 | |
May 09, 2019 | Feb 14, 2011 | Series A | 9267 | |
Oct 17, 2018 | Oct 19, 2011 | Series A | 4795 |
Team profile of Aberdare Ventures
Aberdare Ventures has a team of 4 members including 3 Partners and 1 Venture Partner located in United States. Aberdare Ventures' team sits on the board of 2 companies.Here is a list of all team members in Aberdare Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | United States | |||
Partner | San Francisco | |||
Partner | Raleigh | - | - | |
Venture Partner | - | - | - |
Co-investors of Aberdare Ventures
Over the past 24 years, 218 investors have co-invested in Aberdare Ventures's portfolio companies. This includes funds and angels.
- Invested before Aberdare Ventures: Rock Health, Venrock and 33 others have invested in rounds before Aberdare Ventures. There are 2 companies where Rock Health has invested before Aberdare Ventures and 2 companies where Venrock has invested before Aberdare Ventures.
- Top Co-investors of Aberdare Ventures: 94 investors entered a company along with Aberdare Ventures. These include investors like New Enterprise Associates (4 companies).
- Invested after Aberdare Ventures: A total of 89 investors have invested in Aberdare Ventures's portfolio after their investments. Top Investors include General Electric (3 companies), EDBI (2 companies) and Medtronic (2 companies).
Recent News related to Aberdare Ventures
•
Cricket Health Announces $24 Million Series A Funding Round to Provide Personalized, Cost-Effective Kidney CareBioSpace•Sep 05, 2018•Cricket Health, Oak HC/FT, Liquid 2 Ventures, Cigna and 9 others
•
Boston Scientific Announces Agreement To Acquire NxTheraPR Newswire•Mar 21, 2018•Boston Scientific, NxThera, EMcision, Aberdare Ventures and 1 other
•
Gravie Closes $14M Funding RoundTcbmag•Jul 19, 2017•Gravie, GE Ventures, FirstMark, Aberdare Ventures and 1 other
•
•
•
NxThera Completes $40M FinancingFierceBiotech•Dec 03, 2015•NxThera, Boston Scientific, Aberdare Ventures, Arboretum Ventures
•
Boston Scientific Backs Prostate Device Makers 40M Funding RoundMed Device Online•Dec 03, 2015•NxThera, Boston Scientific, Aberdare Ventures, Arboretum Ventures
•
•
Jiff raises $23M from Rosemark, GE Ventures for employee wellness platform | MobiHealthNewsMobiHealthNews•May 21, 2015•Jiff, GE Ventures, Rosemark Smart Capital, Venrock and 2 others
•
